ICED Conference 2018

Join EDCare at the 2018 International Conference on Eating Disorders (ICED)! We will be exhibiting at Booth 306.

April 19-21, 2018

Chicago Marriott Downtown – Magnificent Mile

540 North Michigan Avenue, (Driveway Entrance on 541 North Rush Street)
Chicago, IL 60611 USA

On Friday, April 20 learn from EDCare’s Executive Clinical Director and Director of Clinical Research Dr. Tamara Pryor and EDCare’s Scientific Advisory Board member Dr. Amy Baker Dennis.

SP4.2 – International Forum on Integrated Treatment for Eating Disorder Patients with Co-morbid Substance Use Disorders: Service Delivery and Access to Care

Substance Use Disorders (especially opiate and cannabis abuse) are on the rise in North America and a significant minority of eating disorder patients present for treatment with co-morbid substance use problems. However, to date, very few specialized eating disorder programs, at any level of care, provide integrated treatment for this co-morbid population. The lack of availability of integrated treatment services for eating disorder patients with co-morbid substance use disorders is not only a significant issue in North America, but also a global concern. During our SIG meeting at ICED 2017 in Prague, treatment providers from Russia, Malaysia, Europe, Japan, the United Kingdom and elsewhere, discussed the lack of evidence-based treatment protocols, the lack of cross-trained treatment providers and the limited access to care in their countries. The Forum will continue the discussion on how we as an international professional community can more effectively address the treatment needs of the co-morbid patient. The long-range goal of the ED/SUD SIG is to develop an international research consortium that will collaborate on finding evidence-based protocols for our dual diagnosed patients.

Learning Objectives:

• Present preliminary data on the availability of integrated treatment for eating disorder patients with co-morbid substance use disorders in the United States and Italy
• Discuss outcome data from an integrated ED/SUD program and identify issues that impede successful recovery from both disorders
• Provide a “roundtable” discussion with SIG participants to further the development of an international consortium designed to promote access to integrated treatment and promote research on evidence-based interventions for the co-morbid population